Encouraging sustainable commuting in France
At Sobi, we are committed to reducing our environmental impact and supporting employee well-being. As part of this commitment, our team in France has introduced a new mobility initiative to make sustainable commuting more accessible and convenient.
Encouraging greener ways to travel
Since January 2025, employees in France have had access to a mobility platform that simplifies and supports eco-friendly commuting. Sobi covers the cost of this service, allowing employees to partially or fully finance their preferred transportation options, such as bikes, electric scooters, carpooling, and public transport. The benefit can also be used for related expenses, including helmets or maintenance.
The aim is to reduce commuting by personal vehicles, which by far represented the largest share of distance travelled before this initiative began.
A local initiative with a broader impact
This initiative in France contributes to Sobi’s broader ambition to reduce carbon emissions across all scopes and promote responsible business practices. It is not just about improving daily commutes -it’s about fostering long-term sustainability and innovation.
Collaboration in action
The successful rollout of this program was made possible through dedicated teamwork and cross-functional collaboration. By integrating the platform into existing systems and ensuring ease of use, the French team has set a strong example for other regions exploring similar solutions. This initiative shows how practical, local actions can bring our global environmental commitments to life.
We are a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.
Our therapies are concentrated within the areas of Haematology, Immunology and Specialty Care.
We contribute to societies by improving access to treatment of rare diseases.
Every day, we work actively to find better ways to understand and meet patient needs.
Find out more about our business and financial performance.
Here we present our most recent press releases, news articles, and images.
- About
- Therapeutic areas
- Medicines
- Stories
- Sustainability
- Careers
- Investors
- Media
- English
- Swedish